233 related articles for article (PubMed ID: 28294622)
1. Tracking Antibody Distribution with Near-Infrared Fluorescent Dyes: Impact of Dye Structure and Degree of Labeling on Plasma Clearance.
Cilliers C; Nessler I; Christodolu N; Thurber GM
Mol Pharm; 2017 May; 14(5):1623-1633. PubMed ID: 28294622
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of near-infrared (NIR) dye-herceptin conjugates as photoacoustic computed tomography (PCT) probes for HER2 expression in breast cancer.
Bhattacharyya S; Wang S; Reinecke D; Kiser W; Kruger RA; DeGrado TR
Bioconjug Chem; 2008 Jun; 19(6):1186-93. PubMed ID: 18505279
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies.
Terwisscha van Scheltinga AG; van Dam GM; Nagengast WB; Ntziachristos V; Hollema H; Herek JL; Schröder CP; Kosterink JG; Lub-de Hoog MN; de Vries EG
J Nucl Med; 2011 Nov; 52(11):1778-85. PubMed ID: 21990576
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, lymph node uptake, and mechanistic PK model of near-infrared dye-labeled bevacizumab after IV and SC administration in mice.
Wu F; Tamhane M; Morris ME
AAPS J; 2012 Jun; 14(2):252-61. PubMed ID: 22391791
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of near-infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence-guided surgery.
Saccomano M; Dullin C; Alves F; Napp J
Int J Cancer; 2016 Nov; 139(10):2277-89. PubMed ID: 27428782
[TBL] [Abstract][Full Text] [Related]
6. Quantifying multimodal contrast agent biological activity using near-infrared flow cytometry.
Hall MA; Aldrich MB; Azhdarinia A; Lachance PA; Robinson H; Hazen A; Haviland DL; Sevick-Muraca EM
Contrast Media Mol Imaging; 2012; 7(3):338-45. PubMed ID: 22539404
[TBL] [Abstract][Full Text] [Related]
7. Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery.
Debie P; Van Quathem J; Hansen I; Bala G; Massa S; Devoogdt N; Xavier C; Hernot S
Mol Pharm; 2017 Apr; 14(4):1145-1153. PubMed ID: 28245129
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Five Near-Infrared Fluorescent Folate Conjugates in an Ovarian Cancer Model.
García de Jalón E; Kleinmanns K; Fosse V; Davidson B; Bjørge L; Haug BE; McCormack E
Mol Imaging Biol; 2023 Feb; 25(1):144-155. PubMed ID: 34888759
[TBL] [Abstract][Full Text] [Related]
9. Impact of C4'-O-Alkyl Linker on in Vivo Pharmacokinetics of Near-Infrared Cyanine/Monoclonal Antibody Conjugates.
Sato K; Nagaya T; Nakamura Y; Harada T; Nani RR; Shaum JB; Gorka AP; Kim I; Paik CH; Choyke PL; Schnermann MJ; Kobayashi H
Mol Pharm; 2015 Sep; 12(9):3303-11. PubMed ID: 26261913
[TBL] [Abstract][Full Text] [Related]
10. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
[TBL] [Abstract][Full Text] [Related]
11. Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma.
Day KE; Beck LN; Deep NL; Kovar J; Zinn KR; Rosenthal EL
Laryngoscope; 2013 Nov; 123(11):2681-9. PubMed ID: 23616260
[TBL] [Abstract][Full Text] [Related]
12. Structurally symmetric near-infrared fluorophore IRDye78-protein complex enables multimodal cancer imaging.
Yang J; Zhao C; Lim J; Zhao L; Tourneau RL; Zhang Q; Dobson D; Joshi S; Pang J; Zhang X; Pal S; Andreou C; Zhang H; Kircher MF; Schmitthenner H
Theranostics; 2021; 11(6):2534-2549. PubMed ID: 33456558
[No Abstract] [Full Text] [Related]
13. Site-Specific Fluorescent Labeling of Antibodies and Diabodies Using SpyTag/SpyCatcher System for In Vivo Optical Imaging.
Alam MK; El-Sayed A; Barreto K; Bernhard W; Fonge H; Geyer CR
Mol Imaging Biol; 2019 Feb; 21(1):54-66. PubMed ID: 29948640
[TBL] [Abstract][Full Text] [Related]
14. Effect of charge localization on the in vivo optical imaging properties of near-infrared cyanine dye/monoclonal antibody conjugates.
Sato K; Gorka AP; Nagaya T; Michie MS; Nakamura Y; Nani RR; Coble VL; Vasalatiy OV; Swenson RE; Choyke PL; Schnermann MJ; Kobayashi H
Mol Biosyst; 2016 Oct; 12(10):3046-56. PubMed ID: 27452807
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of near infrared fluorescent labeling of monoclonal antibodies as a tool for tissue distribution.
Conner KP; Rock BM; Kwon GK; Balthasar JP; Abuqayyas L; Wienkers LC; Rock DA
Drug Metab Dispos; 2014 Nov; 42(11):1906-13. PubMed ID: 25209366
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
[TBL] [Abstract][Full Text] [Related]
17. Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green.
Carr JA; Franke D; Caram JR; Perkinson CF; Saif M; Askoxylakis V; Datta M; Fukumura D; Jain RK; Bawendi MG; Bruns OT
Proc Natl Acad Sci U S A; 2018 Apr; 115(17):4465-4470. PubMed ID: 29626132
[TBL] [Abstract][Full Text] [Related]
18. LC-MS/MS strategies for therapeutic antibodies and investigation into the quantitative impact of antidrug-antibodies.
Ewles M; Mannu R; Fox C; Stanta J; Evans G; Goodwin L; Duffy J; Bell L; Estdale S; Firth D
Bioanalysis; 2016 Dec; 8(24):2565-2579. PubMed ID: 27884074
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro evaluation, and in vivo metabolism of fluor/quencher compounds containing IRDye 800CW and Black Hole Quencher-3 (BHQ-3).
Linder KE; Metcalfe E; Nanjappan P; Arunachalam T; Ramos K; Skedzielewski TM; Marinelli ER; Tweedle MF; Nunn AD; Swenson RE
Bioconjug Chem; 2011 Jul; 22(7):1287-97. PubMed ID: 21639144
[TBL] [Abstract][Full Text] [Related]
20. High-Performance Near-Infrared Fluorescent Secondary Antibodies for Immunofluorescence.
Schreiber CL; Li DH; Smith BD
Anal Chem; 2021 Feb; 93(7):3643-3651. PubMed ID: 33566567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
